Jipmer opens research unit for clinical trials of new vaccines
The Hindu
A list of persons interested in participating in clinical trials being prepared
Jipmer has established a research unit to undertake clinical trials of new COVID vaccines that are currently in development stage.
This project is funded by Biotechnology Industry Research Assistance Council (BIRAC), an arm of the Department of Biotechnology, Government of India, through its “Mission COVID Suraksha” programme.
According to a Jipmer press note, six COVID vaccines have received emergency use authorisation in India. However, there is a clear need to develop more vaccines not only to meet the global supply-demand gap, but also for improved features such as a greater effectiveness, fewer side effects and longer duration of protection.
More Related News